|
Canada-0-INVESTIGATORS 회사 디렉토리
|
회사 뉴스 :
- People With Severe Diabetes Are Cured in Small Trial of New Drug
A person’s conventional supplies for treating type 1 diabetes A single infusion of a new treatment, called zimislecel, may have cured 10 out of 12 people with the most severe form of the disease
- Diabetes Breakthrough: New Treatment Eliminates Insulin . . . - SciTechDaily
A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of participants in a study no longer requiring insulin therapy The treatment was safe and well-tolerated, and further trials are planned to confirm these results
- Emerging Breakthroughs In Diabetes Treatment: A New Era Of Hope - Forbes
From promising research to clinical-stage cell therapies and AI software updates, diabetes treatment and management is poised to change like never before
- Mount Sinai Researchers Move Closer to a Cure for Diabetes
Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new understanding of how human beta cell regenerative drugs work These drugs, developed at Mount Sinai, may hold promise for more than 500 million people with diabetes in the world
- Promising new treatment strategy for type 2 diabetes - News-Medical. net
Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin
- Son’s diabetes diagnosis sent scientist on quest for cure
Over the decades, Melton and his colleagues made a series of discoveries that laid the groundwork for a new treatment to restore insulin production in patients with Type 1 diabetes Melton compares this stem cell-derived islet therapy to “educating” a stem cell and its descendants — introducing the protein signals that trigger or inhibit
- FDA Approves First Rapid-Acting Insulin Biosimilar Product for . . .
FDA approved the first rapid-acting biosimilar insulin product, Merilog (insulin-aspart-szij), a biosimilar to its reference product Novolog (insulin aspart), to improve glycemic control in adults
- New Developments in Diabetes Management: A 2025 Perspective
The year 2025 marks a significant milestone in the evolution of diabetes management Technological innovations, pharmaceutical advancements, and lifestyle interventions have collectively transformed the landscape of diabetes care, offering new hope for patients and healthcare providers alike
- Top 7 Breakthroughs in Type 2 Diabetes Treatment for 2025
Type 2 diabetes management continues to evolve, and 2025 promises new hope for millions With pharmaceutical innovations, digital health integrations, and groundbreaking clinical findings, the landscape of diabetes treatment is rapidly shifting
- Top Diabetes Treatment Advancements in 2023 - Healthline
Several advancements and innovations in diabetes treatment and management became available in 2023 These have included new medications, high-tech insulin pumps, and new legislation capping
|
|